Oxford BioDynamics PLC Navigates Stock Volatility Amid Focus on Cancer Diagnostics and Drug Development
Oxford BioDynamics PLC is a biotechnology company focused on cancer diagnostics and drug development, with a market capitalization of £10.08 million and a negative price-to-earnings ratio.
2 minutes to read